Dove Press is a member of the Open Access Initiative, specializing in peer reviewed Medical Journals. View articlesor submit your research for publishing
1 November 2023 in Risk Management and Healthcare Policy
Social egg freezing is an emerging topic in China, where single women currently face restrictions in accessing this service at medical facilities. Administrative regulations prohibit single women from accessing all forms of assisted reproductive technologies. Both the first lawsuit filed by a single woman seeking to freeze her eggs and a legislative proposal aiming to protect single women’s rights to access assisted reproductive technologies were denied. This has sparked controversy and discussion about the reproductive rights of single women and the legitimacy of their access to medical and technical assistance. Laws and family planning policies related to women’s reproductive rights in China have undergone dramatic changes in recent years, owing to shifts in population growth trends and societal attitudes toward marriage and childbirth, subsequently leading to a notable enhancement in women’s reproductive autonomy. Meanwhile, factors such as marital status and career considerations have led to a delay in childbearing, triggering a growing need and advocacy for fertility preservation among single women. In China, the pursuit of social egg freezing by single women comes into conflict with the strict regulatory restrictions on assisted reproductive technologies. This study delves into the profound impacts of demographic changes, marital trends, fertility culture, and other social factors on female fertility in China. It also discusses the legislative issues and medical-social ethical concerns associated with the application of social egg freezing for single women. Additionally, this study offers regulatory suggestions aimed at enhancing women’s reproductive health and autonomy, as well as the avoidance of potential ethical risks.
15 November 2023 in Humanities and Social Sciences Communications
Surrogacy has grown significantly as an underground industry in China over the last two decades. Accordingly, an increasing number of surrogate mothers are being bound by surrogacy contracts. As surrogacy contracts are unregulated in China, the contractual obligations of surrogacy may cause serious harm to surrogate mothers due to the infringement of their rights and increased risk of injury. Sociocultural concerns and financial considerations have made surrogate mothers hesitant to seek legal remedies. Additionally, gaps in the legislative and judicial rules make it difficult for surrogate mothers to receive sufficient compensation after suffering injuries. This study examines the infringement of the rights of surrogate mothers and potential injuries to them during surrogacy transactions and contract fulfillment. Furthermore, it presents the current legal framework of surrogacy regulation and remedies for preserving the rights of surrogate mothers. The causes of the current dilemma of protecting rights are analyzed, and regulative and legislative suggestions for preventing injury and providing legal remedies are offered.
Background: In March 2026, China approved the first invasive brain‑computer interface (BCI) for clinical use globally. While this milestone accelerates neurotechnology translation, it exposes a neglected ethical problem: in some long-term invasive BCI cases, participants who initially consent to later device explantation may subsequently develop functional dependence on, and phenomenological incorporation of, the device. This paper examines whether such post-implantation integration can weaken the continuing moral authority of initial consent to explantation. Methods: This paper provides a normative analysis grounded in established bioethics concepts. We draw on theories of extended cognition and transformative experience, integrate findings from qualitative empirical studies of BCI user phenomenology, and engage with the neurorights discourse and Chinese regulatory developments. The analysis focuses on the moral authority of initial consent where long-term device integration may alter the participant’s embodied agency, with particular attention to the implications for interpreting the right to withdraw from research. Results: Transformative experience alone is not sufficient to distinguish implantable BCIs from other medical interventions that may also alter self-understanding. The distinctive diachronic consent problem arises when ex ante experiential ignorance is combined with extended cognition, embodied agency, functional dependence, and the possibility that explantation would remove a device experienced as part of the user’s agential system. We identify a specific governance gap in China’s current ethical guidelines and propose three interlocking reforms: adopting a dynamic consent model with periodic re‑consent encounters, establishing ongoing ethical review for implanted participants, and decoupling withdrawal from research from consent to explantation. An ethical algorithm to guide explantation decisions is presented. Conclusions: Informed consent for long-term invasive BCI use should be reconceptualised as an ongoing process where there is evidence of functional dependence or phenomenological incorporation. Initial consent remains important, but it should not be treated as conclusively authorising later explantation without post-integration reassessment.